More data sought on Sputnik V vaccine

JAMMU & KASHMIR

217,910

PUNJAB

139,438

HARYANA

276,536 DELHI

337,080

GUJARAT

830,098

DAMAN & DIU, DADRA AND NAGAR HAVELI

6,855

GOA

17,872

KARNATAKA

581,965

KERALA

421,298

LAKSHADWEEP

2,344 TAMIL NADU

414,741

RAJASTHAN

783,205

CHANDIGARH

18,640 UTTARAKHAND

155,798

UTTAR PRADESH

1,140,754

MADHYA PRADESH

645,122

MAHARASHTRA

1,080,675

PUDUCHERRY

9,436

NEW DELHI: It will be some time before Sputnik V, the Russia-developed vaccine against the Coronavirus disease (Covid-19), is approval for use in India. The subject expert committee (SEC) of the national drug regulator asked Dr. Reddy’s Laboratories, which is conducting clinical trials on it locally, to come back with more data.

LADAKH

7,368

HIMACHAL PRADESH

98,909

MEGHALAYA

36,589

ASSAM

179,526

ARUNACHAL PRADESH

22,433

NAGALAND

32,295

SIKKIM

15,702

BIHAR

562,056

WEST BENGAL

800,000

JHARKHAND

293,490

ODISHA

447,797

CHHATTISGARH

361,669

TELANGANA

293,151

ANDHRA PRADESH

528,402

TOTAL BENEFICIARIES VACCINATED ACROSS INDIA

Hyderabad-based Dr Reddy’s applied for emergency use authorization (EUA) to the Central Drugs Standard Control Organisation (CDSCO) on February 19 for the human adenoviral vector-based vaccine candidate.

The subject expert committee took up the application on Wednesday, but did not recommend that the vaccine be

MIZORAM

18,485 TRIPURA

91,625

ANDAMAN AND NICOBAR

5,644

MANIPUR

45,949 approved for use in India with the current data set that was produced before its members.

“The subject expert committee has sought more data such as the immunogenicity data from the company. The application has not been rejected, they will be given a chance to present their case ,” said a senior government official.